1. |
Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol 2020;27:27-42.
|
2. |
Nelson TJ, Truong T, Truong B, Bilyeu CV, Zhao J, Stains CI. A luminescence-based assay for monitoring changes in alpha-synuclein aggregation in living cells. RSC Adv 2020;10:16675-8.
|
3. |
Ball N, Teo WP, Chandra S, Chapman J. Parkinson's disease and the environment. Front Neurol 2019;10:218.
|
4. |
Marino BL, de Souza LR, Sousa KP, Ferreira JV, Padilha EC, da Silva CH, et al. Parkinson's disease: A review from pathophysiology to treatment. Mini Rev Med Chem 2020;20:754-67.
|
5. |
Cinar E, Yalcin-Cakmakli G, Saka E, Ulusoy A, Yuruker S, Elibol B, et al. Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy? Exp Neurol 2020;330:113357.
|
6. |
Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA 2020;323:548-60.
|
7. |
Elia LP, Reisine T, Alijagic A, Finkbeiner S. Approaches to develop therapeutics to treat frontotemporal dementia. Neuropharmacology 2020;166:107948. doi: 10.1016/j.neuropharm.2020.107948. Epub 2020 Jan 8. PMID: 31962288.
|
8. |
Fogel Y, Rosenblum S, Hirsh R, Chevignard M, Josman N. Daily performance of adolescents with executive function deficits: An empirical study using a complex-cooking task. Occup Ther Int. 2020 Feb 6;2020:3051809. doi: 10.1155/2020/3051809. PMID: 32099539; PMCID: PMC7026736.
|
9. |
Li S, Ou R, Yuan X, Liu H, Hou Y, Wei Q, et al. Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson's disease. J Affect Disord 2019;243:525-30.
|
10. |
Meyer A, Zimmermann R, Gschwandtner U, Hatz F, Bousleiman H, Schwarz N, Fuhr P. Apathy in Parkinson's disease is related to executive function, gender and age but not to depression. Front Aging Neurosci 2015;6:350.
|
11. |
Jaywant A, Musto G, Neargarder S, Gilbert KS, Cronin-Golomb A. The effect of Parkinson's disease on verbal and non-verbal fluency. J Clin Neuropsychol 2014;36:278-89.
|
12. |
Marin D, Madotto E, Fabbro F, Skrap M, Tomasino B. Design fluency and neuroanatomical correlates in 54 neurosurgical patients with lesions to the right hemisphere. J Neurooncol 2017;135:141-50.
|
13. |
Kuiper JS, Oude Voshaar RC, Verhoeven FE, Zuidema SU, Smidt N. Comparison of cognitive functioning as measured by the ruff figural fluency test and the CogState computerized battery within the LifeLines Cohort Study. BMC Psychol 2017;5:15.
|
14. |
Harter SL, Hart CC, Harter GW. Expanded scoring criteria for the design fluency test: Reliability and validity in neuropsychological and college samples. Arch Clin Neuropsychol 1999;14:419-32.
|
15. |
Marinus J, Visser M, Stiggelbout AM, Rabey JM, Martínez-Martín P, Bonuccelli U, Kraus PH, van Hilten JJ. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry. 2004;75:388-95.
|
16. |
Barekatain M, Walterfang M, Behdad M, Tavakkoli M, Mahvari J, Maracy MR, et al. Validity and reliability of the Persian language version of the neuropsychiatry unit Cognitive Assessment Tool. Dement Geriatr Cogn Disord 2010;29:516-22.
|
17. |
Asaadi S, Ashrafi F, Omidbeigi M, Nasiri Z, Pakdaman H, Amini-Harandi A. Persian version of frontal assessment battery: Correlations with formal measures of executive functioning and providing normative data for Persian population. Iran J Neurol 2016;15:16-22.
|
18. |
Gullett JM, Price CC, Nguyen P, Okun MS, Bauer RM, Bowers D. Reliability of three Benton Judgment of line orientation short forms in idiopathic Parkinson's disease. Clin Neuropsychol 2013;27:1167-78.
|
19. |
Jones-Gotman M, Milner B. Design fluency: The invention of nonsense drawings after focal cortical lesions. Neuropsychologia 1977;15:653-74.
|
20. |
Varney NR, Roberts RJ, Struchen MA, Hanson TV, Franzen KM, Connell SK. Design fluency among normals and patients with closed head injury. Arch Clin Neuropsychol 1996;11:345-53.
|
21. |
Uysal-Cantürk P, Hanağası HA, Bilgiç B, Gürvit H, Emre M. An assessment of movement disorder society task force diagnostic criteria for mild cognitive impairment in Parkinson's disease. Eur J Neurol 2018;25:148-53.
|
22. |
Bezdicek O, Růžička F, Fendrych Mazancova A, Roth J, Dušek P, Mueller K, et al. Frontal assessment battery in Parkinson's disease: Validity and morphological correlates. J Int Neuropsychol Soc 2017;23:675-84.
|
23. |
Jaywant A, Musto G, Neargarder S, Gilbert KS. The effect of Parkinson's disease subgroup on verbal and non-verbal fluency. J clin Exp Neuropsychol 2014;36:278-89.
|
24. |
Koerts J, Van Beilen M, Tucha O, Leenders KL, Brouwer WH. Executive functioning in daily life in Parkinson's disease: Initiative, planning and multi-task performance. PLoS One 2011;6:e29254.
|